Current breast screening services available throughout Europe to families at increased genetic risk for breast cancer

H. Gregory*, B. Milner, N. E. Haites, M. Caligo, J. Chang-Claude, D. M. Eccles, D. G. Evans, S. Hodgson, P. Møller, P. Morrison, C. M. Steel, D. Stoppa-Lyonnet, H. Vasen

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Breast cancer is a common disease, with up to 5% thought to be due to inherited gene mutations. Services for surveillance of women at increased genetic risk of breast cancer have been evolving throughout Europe as a result of evidence-based medicine and increasing public awareness. The Biomed 2 Demonstration Project was established to evaluate these services, in order to propose an "ideal model" for management of individuals at increased risk of breast cancer. Data was collected by questionnaire as part of this project from centres in 10 European Union and 17 non-European Union countries, including funding, clinic organization, referral patterns, risk assessment and screening for breast and other related cancers. Many similarities in provision of serviced for women at increased risk of breast cancer were evident in those countries studied. There were some differences in certain aspects of management such as prophylactic mastectomy. With increasing population mobility and communications, it appears appropriate to have a consensus throughout Europe for the management of high risk individuals.

Original languageEnglish
Pages (from-to)248-253
Number of pages6
JournalCME Journal of Gynecologic Oncology
Volume5
Issue number3
Publication statusPublished - 1 Dec 2000

Keywords

  • Biomed 2
  • Breast cancer
  • Familial
  • Genetic clinic
  • Screening

Fingerprint

Dive into the research topics of 'Current breast screening services available throughout Europe to families at increased genetic risk for breast cancer'. Together they form a unique fingerprint.

Cite this